NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Tru-D UVC Disinfection Robot

Tru-D UVC Disinfection Robot

The Tru-D device, part of PDI’s infection prevention solutions, is a portable UVC disinfection robot that delivers one automated, measured dose of UVC to consistently disinfect a room, resulting in the ability to document disinfection results after each and every room treatment. The Tru-D robot operates from one placement within the room, ensuring significant pathogen reduction in direct and shadowed areas and reducing the threat of human error in the disinfection process. Validated by more than 20 independent studies, the Tru-D device’s combined automated, measured dosing capabilities and real-time usage-tracking features make it one of the most precise and advanced UVC disinfection systems available.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X